Design-Elememt

Benefits assessment

7. February 2007

Restart required for all ongoing IQWiG procedures

 
Dr. Klaus Theo Schröder, state secretary at the German Federal Ministry of Health, made it clear during yesterday's 12th Annual Handelsblatt Conference "Pharma 2007" in Frankfurt (Main) that all ongoing assessment procedures of the Institute for Quality and Economy in the Health Care Sector (IQWiG) must be reopened.

Dr. Steffen Wahler, director of health economics at the German Association of Research-based Pharmaceutical Companies (VFA): "As part of the health care reform, the legislature wants to stipulate new benchmarks for the work of the IQWiG. Mandates for the Cologne-based institute include especially the orientation on internationally customary standards, significantly improved work transparency and appropriate patient participation. Effective immediately, all ongoing procedures must follow these requirements. Therefore, we welcome this clarification by State Secretary Schröder."

"Of course, there is also the question, if the IQWiG's contractor - the Federal Joint Committee (G-BA) can adhere to decisions that were made without appropriate patient participation during the individual procedural steps," Wahler added.

Stand: 07.02.2007

Read also: VFA Position Paper "Requirements for a health economic assessment in Germany"
Icon Suggest pageSuggest page Icon Print pagePrint page Icon Bookmark pageBookmark page
The Pharmaceutical Industry in Germany

Germany: The Perfect Location for Research, Production and Sales - a publication by GERMANY TRADE & INVEST and vfa
Brochure Download